Brain Tumors Clinical Trials
Study of IDO Inhibitor and Temozolomide for adult patients with primary malignant brain tumors. Click here to learn more.
Head & Neck Cancer Clinical Trials
BI 1200.131 LUX-Head&Neck 2
A Phase III trial of Afatinib (BIBW 2992) vs. placebo for the treatment of head and neck squamous cell cancer after treatment with chemo-radiotherapy. Click here to learn more.